Literature DB >> 10710058

Prevalence of celiac disease among blood donors in Brazil.

L Gandolfi1, R Pratesi, J C Cordoba, P L Tauil, M Gasparin, C Catassi.   

Abstract

OBJECTIVE: There are no studies on the prevalence of celiac disease (CD) in either Brazil or, as far as we know, South America. The aim of this study was to determine the prevalence of CD in healthy blood donors in the city of Brasilia, Brazil.
METHODS: Sera were obtained, independently of age and gender, from an unselected group of 2045 blood donors attending the Hematological Center of Brasilia. An IgG antigliadin antibody (AGA) test was used as a first-level screening step, followed by IgA-AGA test, serum IgA antiendomysium (EMA), and total serum IgA determination performed in all sera showing abnormally high IgG-AGA results. Jejunal biopsy was suggested for all subjects showing at least one of the following: IgA-EMA positivity; IgG-AGA and IgA-AGA positivity; IgG-AGA positivity and selective IgA deficiency. AGA was determined by an enzyme-linked immunosorbent assay (ELISA) technique and IgA-EMA was ascertained by indirect immunofluorescence on cryostat sections of monkey esophagus. Jejunal mucosa samples were obtained with a Watson capsule.
RESULTS: Sixty-two (3.03%) blood donors had IgG-AGA above the cut-off values. Fifty-eight individuals showed isolated high values of IgG-AGA, whereas four had simultaneously increased IgG and IgA-AGA. Three patients had positive IgA-EMA test (one with both IgG- and IgA-AGA and two with only IgG-AGA) and underwent jejunal biopsies that disclosed complete villous atrophy associated with an increased number of intraepithelial lymphocytes and hypertrophic criptae. In this study group, the prevalence of biopsy-proven celiac disease was 1.47 +/- 1.66 in 1000 subjects.
CONCLUSIONS: We found a prevalence of undiagnosed CD of 1:681 among apparently healthy blood donors. These preliminary results support the view that CD is not a rare disease in Brazil.

Entities:  

Mesh:

Year:  2000        PMID: 10710058     DOI: 10.1111/j.1572-0241.2000.01847.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  32 in total

1.  Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.

Authors:  Reem Z Sharaiha; Ben Lebwohl; Laura Reimers; Govind Bhagat; Peter H Green; Alfred I Neugut
Journal:  Cancer       Date:  2011-12-13       Impact factor: 6.860

2.  Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil.

Authors:  Suzeidi Bernardo Castanheira Melo; Maria Inez Machado Fernandes; Luiz Cesar Peres; Luiz Ernesto Almeida Troncon; Livia Carvalho Galvão
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

Review 3.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Celiac disease prevalence in Brazilian dilated cardiomyopathy patients.

Authors:  Ricardo Schmit T De Bem; Shirley Ramos Da Ro Sa Utiyama; Renato Mitsunori Nisihara; Jerônimo Antônio Fortunato; Josué Augusto Tondo; Eliane Ribeiro Carmes; Raquel Almada E Souza; Julio César Pisani; Heda Maria Barska Dos Santos Amarante
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

5.  Celiac disease in the Turkish population.

Authors:  Rengin Elsurer; Gonca Tatar; Halis Simsek; Yasemin H Balaban; Musa Aydinli; Cenk Sokmensuer
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

6.  The changing face of celiac disease.

Authors:  R Lad; K Jacobson
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 7.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

8.  Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population.

Authors:  Gonca Tatar; Rengin Elsurer; Halis Simsek; Yasemin H Balaban; Gulsen Hascelik; Osman I Ozcebe; Yahya Buyukasik; Cenk Sokmensuer
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

9.  Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry.

Authors:  Maria Angélica G Pereira; Carmen L Ortiz-Agostinho; Iêda Nishitokukado; Maria-N Sato; Adérson O M C Damião; Marília L Alencar; Clarice P Abrantes-Lemos; Eduardo L R Cançado; Thales de Brito; Sérgio O Ioshii; Sandra B M Valarini; Aytan M Sipahi
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.

Authors:  Nicola G Cascella; Debra Kryszak; Bushra Bhatti; Patricia Gregory; Deanna L Kelly; Joseph P Mc Evoy; Alessio Fasano; William W Eaton
Journal:  Schizophr Bull       Date:  2009-06-03       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.